Skip to content
Search

Latest Stories

Govt claims 'major milestone' with two billion PPE items delivered to NHS and social care staff

Two billion personal protection equipment (PPE) items have been delivered to the NHS and social care staff across the UK since the start of the Covid-19 outbreak, the government said on Thursday (June 25).

As many as 341 million masks, 313 million aprons, four million gowns and 1.1 billion gloves have been delivered to frontline workers in a bid to ensure the safety of the health, social care workers.


Almost 28 billion items of PPE have been ordered overall from UK-based manufacturers and international partners to provide a continuous supply in the coming months.

Health Secretary Matt Hancock said: “Coronavirus has placed unprecedented global demands on PPE supply chains. To tackle this we set a national challenge calling on companies to channel their manufacturing power into manufacturing much-needed PPE, and brought in Lord Deighton who has truly delivered once more for his country.

“Two billion items of PPE have now been delivered to the frontline, and a further 28 billion items sourced, that will protect frontline workers well into the future.

“It is thanks to the herculean effort from UK industry, the NHS and departmental teams, our diplomatic teams abroad, and the armed forces that we have now hit this impressive milestone.”

The normal supply chain for PPE was designed to accommodate delivery to 226 NHS Trusts, but essential PPE supplies are now being supplied to 58,000 different settings, including care homes, hospices and community care organisations.

Lord Paul Deighton, adviser to the health secretary on PPE, said: “The driving motivation of our team has been to supply our frontline workers with the PPE they need so they can focus on saving lives. This is why hitting this milestone matters and why I am so grateful to all the individuals and companies, both in the UK and overseas, who have contributed to this effort.

“Responding to a massive spike in our requirements and a significant global supply shortage, we have in a matter of weeks scaled up our international procurement, our domestic manufacturing and our logistics and distribution capabilities so that we can deliver PPE to where it’s needed.”

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less